Join
Live feed
·
PRReleasevia Quantisnow
EQRx Inc. logo

EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer

ByQuantisnow·Wall Street's wire, on your screen.
EQRX· EQRx Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EQRX (EQRx Inc.) and more on Quantisnow.